When Adult Eczema Does Not Respond: What Diagnostic Testing Guidelines Recommend

Evidence summary for education only; not individualized medical advice.

Treatment resistance is a diagnostic signal

Some adults labeled with atopic dermatitis do not improve despite optimized topical or systemic care. A 2026 practice guideline addresses diagnostic testing in presumed adult eczema that remains refractory.

Questions before another medication

Clinicians can reassess adherence, amount applied, body sites, exposure to irritants or allergens and whether the original morphology fits eczema. Allergic contact dermatitis, irritant dermatitis, scabies, psoriasis, cutaneous T-cell lymphoma, immunodeficiency and infection may mimic or coexist with atopic dermatitis.

Testing should follow the differential

Patch testing evaluates delayed contact allergy. Skin scraping or culture addresses selected infectious questions. Biopsy can help when morphology, age of onset or course is atypical. Laboratory or immune work-up is targeted to history rather than ordered as a broad screening panel.

Why escalation alone can be harmful

Increasing immunosuppression when the diagnosis is wrong can delay recognition of infection or malignancy. Conversely, fear of rare mimics should not lead to indiscriminate testing in otherwise typical, responsive eczema.

Adult-onset disease deserves attention

New widespread dermatitis later in life, systemic symptoms, unexplained weight loss, unusual lymph nodes or persistent lesions in unexpected areas should be reported. Treatment should not be stopped abruptly without the prescriber while evaluation proceeds.

Bottom line

Refractory eczema should trigger a structured reassessment of diagnosis, exposure and adherence. Testing is most valuable when it answers a specific competing hypothesis.

Related Dr. Arsy research

• Choosing an eczema moisturizer
• Eczema infection warning signs
• Eczema and sleep
• Eczema across skin tones
• Comparing eczema treatments
• Pediatric eczema education

References

1. Diagnostic testing guideline for refractory adult eczema
2. Food allergy testing guideline comparison
3. Patch testing in atopic dermatitis consensus
4. Infectious complications of atopic dermatitis
5. Vaccination during biologic therapy review
6. AAAAI/ACAAI GRADE guideline
7. 2026 pediatric guideline
8. AAD topical therapy guideline
9. AAD systemic therapy guideline
10. Food allergy and atopic dermatitis review
11. Elimination diets systematic review
12. Early allergenic-food introduction meta-analysis
13. LEAP peanut trial
14. Eczema herpeticum review
15. Systemic antibiotic use in eczema review
16. Topical antimicrobials Cochrane review
17. S aureus and eczema review
18. Atopic dermatitis microbiome review
19. Contact dermatitis clinical review
20. Atopic dermatitis clinical review
21. HOME core outcome set
22. POEM validation
23. RECAP control instrument
24. Pediatric biologic systematic review

Cited researchers and organizations do not endorse #003.